A recent study suggests that the drug pricing agreement between Britain and Donald Trump could result in a higher death toll than the Covid-19 pandemic if NHS funds are redirected to cover the costs. The analysis projects that by 2036, around 229,000 lives could be lost if resources are shifted from other essential NHS services to pay for expensive medications from US pharmaceutical companies, requiring an additional £45 billion in NHS funding. This move, made to satisfy President Trump’s demands, would likely reduce the financial resources available for NHS personnel and equipment.
President Trump had previously threatened significant tariffs on drug imports from UK companies unless the NHS purchased pricier drugs from American firms. The NHS historically secured more cost-effective drug prices than private hospitals in the US due to its collective bargaining power.
The study, published in the British Medical Journal, indicates that without adequate funding to cover the shortfall, there could be 229,000 preventable deaths by 2036, potentially rising to 291,000 when considering the impact on adult social care. In comparison, the study notes that there were 137,000 Covid-19-related deaths between March 2020 and June 2022.
The agreement stipulates an increase in spending on new drugs from 0.3% to at least 0.6% of GDP by 2036. This change is expected to lead to the approval of expensive drugs like immunotherapy treatments for cancer, which can cost hundreds of thousands of pounds per dose. However, the lack of additional funding to cover these costs may result in reduced resources for NHS staff and critical infrastructure.
The government’s decision to accommodate industry pressure while passing on costs to the NHS raises concerns about transparency and accountability. Campaigners have raised objections to the deal, fearing that billions allocated for crucial NHS services may be diverted to pharmaceutical companies. They urge the government to reconsider the agreement and prioritize the health and well-being of the population.
